| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |